Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is an effective and safe treatment for alopecia areata.

Low ferritin, vitamin D deficiency, and thyroid problems may contribute to hair loss in some hospital patients in Western Saudi Arabia.

The document's conclusion cannot be provided because the content is not accessible.

The document concludes that follicular unit transplantation offers more natural results and better graft survival than older hair transplant methods.

Accurate diagnosis and effective oral treatment are key to managing tinea capitis and preventing its spread.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Oral dutasteride can potentially treat frontal fibrosing alopecia in postmenopausal women, with some patients showing disease arrest and hair regrowth.

The normal human prostate does not significantly affect blood DHT levels.

Trichohyalin is modified by enzymes to form strong structures in hair cells.

The document could not be processed to provide a conclusion.

Finasteride helps female-pattern hair loss.

A child with trichothiodystrophy also had autoimmune thyroiditis and anemia, which is a new finding.

The paper suggests that France's suspension of Diane-35 was hasty and could cause treatment issues and unintended pregnancies, recommending a re-evaluation and better patient information.

Telogen effluvium negatively affects quality of life, increasing stress, depression, and anxiety.

Hair-Thread Tourniquet Syndrome is a rare condition where hair or thread tightly wraps around a child's body part, requiring quick treatment to prevent damage.

Titanflow improves male urinary health by strengthening the detrusor muscle and enhancing urine flow.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

The study found two new mutations in a Chinese patient with severe biotinidase deficiency.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

Managing telogen effluvium is challenging due to limited scientific evidence.

Aging reduces skin cell renewal and defense against germs due to TGFbeta, but blocking TGFbeta could help restore these functions.

The FFA-QLI is a reliable tool for assessing quality of life in women with severe Frontal Fibrosing Alopecia.

Follicular Unit Hair Transplantation is a method for restoring hair by transplanting individual hair follicles.

Tissue-engineered skin substitutes can model junctional epidermolysis bullosa and may help develop gene therapy.

Tofacitinib helped a man with alopecia totalis regrow all his hair.

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.